Ipamorelin (Research-Grade Peptide)

Selective growth hormone secretagogue — for laboratory research only

Product Overview

Ipamorelin is a synthetic pentapeptide that functions as a selective agonist of the growth hormone secretagogue receptor
(GHS-R). Unlike earlier GHS compounds, Ipamorelin has been studied for its ability to stimulate pulsatile growth hormone
release with minimal interaction with cortisol or prolactin pathways. It has been investigated in preclinical and clinical
research related to endocrine signaling, metabolism, and tissue recovery mechanisms. Supplied as a high-purity
lyophilized powder, this material is intended strictly for laboratory research use and is not approved for human or
veterinary administration.

Research Highlights

• GHS-R Selectivity: Ipamorelin selectively activates the growth hormone secretagogue receptor, promoting
  GH release without significant stimulation of ACTH, cortisol, or prolactin in research models.
  European Journal of Endocrinology
• Pulsatile GH Release: Studies indicate that Ipamorelin supports physiologic, pulsatile GH secretion,
  a key focus in endocrine and metabolic research.
  Journal of Clinical Endocrinology & Metabolism
• Metabolic & Tissue Research: Ipamorelin has been explored in animal models for its effects on protein
  synthesis, nitrogen balance, and tissue repair signaling pathways.
  Growth Hormone & IGF Research
• Comparative GHS Studies: Research comparing Ipamorelin to earlier GHS compounds highlights its improved
  receptor specificity and reduced off-target endocrine activity.
  Peptides

Product Details & Handling

• Synonyms: Ipamorelin; NNC 26-0161
• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
• Form: Lyophilized powder, supplied in sterile vials
• Purity: ≥ 98% (Certificate of Analysis provided)
• Storage: Store at –20 °C; protect from light and moisture
• Handling: For use only in controlled laboratory environments with appropriate PPE; consult SDS for safety information

Legal Disclaimer

This product is provided strictly for laboratory research use only.
It is not intended for human or veterinary consumption, therapeutic, diagnostic, or clinical application.
Customers are responsible for compliance with all applicable laws and institutional policies.
Ipamorelin is an investigational research compound and is not approved by the FDA as a drug, supplement, or treatment.
Windy City Peptide does not provide medical advice or support related to human use.